A major prerequisite toward development of vaccine(s) or therapeutic regimens for tuberculosis is a thorough understanding of the immune responses initiated following infection of macrophages and DCs by Mycobacterium tuberculosis (M. tb)2 (1-4). A key factor toward this is cross-regulation of cytokine secretion by different cells of the immune system (5-7). One of the molecules that regulate cytokine expression and cytokine receptor-mediated gene expression in various cells of the immune system is a family of closely related proteins called Suppressors of Cytokine Signaling (SOCS). There are currently eight members of SOCS proteins (SOCS1-7 and CIS (also called SOCS8)), with SOCS1 being the most characterized (8). All eight SOCS family members have a central Src homology 2 domain, an N-terminal domain of variable length, and a 40-amino acid motif at the C terminus known as the SOCS box. Although SOCS molecules exhibit sequence homology, particularly in the SOCS box and Src homology 2 domains, CIS and SOCS2, SOCS1 and SOCS3, SOCS4 and SOCS5, and SOCS6 and SOCS7 have marked pairwise homology across the entire protein sequence. SOCS molecules bind to the cytoplasmic tails of cytokine receptors and block their activation. This consequently leads to a block in the effects of the cytokine in question and leads to skewing of responses.Although macrophages serve as the long term hosts for mycobacteria, DCs phagocytose mycobacteria and mycobacterial antigens, and these interactions are crucial for the development of protective immunity (9 -11). As a result DC function and phenotype are modified following bacterial uptake. A number of surface receptors, e.g. Toll-like receptor (TLR) 2, mannose receptor, CD11b (Mac-1), CD11c, and DEC-205 have been implicated in mycobacterial recognition by DCs,[12][13][14].